CenterHumanNatureAINeuroscience $CHAIN
69
PumpScore 69/100 Grade B
CHAIN, the ticker for CenterHumanNatureAINeuroscience, scores 69 out of 100 on PumpScore as of Aug 15, 2026 08:30. That grade reflects thin liquidity, active 24-hour volume and balanced order flow on the Solana blockchain.
Score breakdown
The biggest contributor to its score is trade participation (100/100), while survival time (5/100) is the weakest link holding it back.
Liquidity depth36
Liquidity vs market cap100
24h trading volume87
Healthy turnover55
Buy / sell balance86
Trade participation100
Survival time5
Market-cap tier28
Price stability91
Volume vs liquidity82
Price
$0.0000032
Market Cap
$3.2K
24h Volume
$48.2K
Liquidity
$2.8K
24h Change
-89.77%
24h Buys / Sells
597 / 632
Tip Low on trading activity? Many Solana creators use a volume bot for Pump.fun to build steady volume and chase King of the Hill.
Contract
BP42NQ7tkcxq82AXgC1i5wT1QtUNCUUJvQyULeQbpump
Frequently asked questions
When did CHAIN launch?
CenterHumanNatureAINeuroscience launched on Pump.fun about 1 hour ago. Survival time is part of the score - the longer a token trades without collapsing, the more its structure is trusted.
Where can I buy CHAIN?
You can find CenterHumanNatureAINeuroscience on Pump.fun and Solana DEXs. Verify the exact contract address on a block explorer first, since copycat tickers are common.
What is the market cap of CenterHumanNatureAINeuroscience?
As of Aug 15, 2026 08:30, CHAIN trades at $0.0000032 with a market cap near $3.2K, $48.2K of 24h volume and $2.8K of liquidity. It moved -89.77% over the last day.
How is CHAIN rated on PumpScore?
CenterHumanNatureAINeuroscience (CHAIN) has a PumpScore of 69/100 - Grade B, healthy - as of Aug 15, 2026 08:30. The rating is built from 10 live on-chain signals such as liquidity, volume, buy/sell balance and survival time.
Can I trust CenterHumanNatureAINeuroscience?
No score can prove CHAIN is safe. CenterHumanNatureAINeuroscience carries thin liquidity and a 69/100 structure read, but brand-new tokens can fail regardless. Treat this as data, not advice.
